Regeneron Pharmaceuticals Inc (REGN)
Operating return on assets (Operating ROA)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 3,688,200 | 3,840,900 | 3,831,000 | 3,990,700 | 4,051,200 | 4,082,700 | 4,029,600 | 4,281,000 | 4,545,700 | 4,558,400 | 4,848,800 | 5,132,600 | 6,456,900 | 7,080,400 | 9,120,700 | 8,946,800 | 7,474,100 | 6,680,000 | 3,989,200 | 3,576,600 |
| Total assets | US$ in thousands | 40,169,400 | 38,219,200 | 37,545,200 | 37,759,400 | 37,441,900 | 36,086,800 | 34,369,600 | 33,080,200 | 32,163,300 | 30,657,500 | 30,059,900 | 29,214,500 | 27,677,800 | 27,205,800 | 26,348,700 | 25,434,800 | 23,671,500 | 21,485,900 | 17,772,200 | 17,163,300 |
| Operating ROA | 9.18% | 10.05% | 10.20% | 10.57% | 10.82% | 11.31% | 11.72% | 12.94% | 14.13% | 14.87% | 16.13% | 17.57% | 23.33% | 26.03% | 34.62% | 35.18% | 31.57% | 31.09% | 22.45% | 20.84% |
September 30, 2025 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $3,688,200K ÷ $40,169,400K
= 9.18%
Peer comparison
Sep 30, 2025
Company name
Symbol
Operating ROA
Regeneron Pharmaceuticals Inc
REGN
9.18%
Arrowhead Pharmaceuticals Inc
ARWR
7.10%
Biomarin Pharmaceutical Inc
BMRN
8.08%